United States Radiation Toxicity Treatment Market 2025 | Growth Drivers, Competitive Landscape & Investment Opportunities

Market Size and Growth

The Global Radiation Toxicity Treatment Market reached US$ 2.9 billion in 2022 and is expected to reach US$ 4.6 billion by 2030 growing with a CAGR of 6.1% during the forecast period 2023-2030.

Key Development:

United States: Recent Industry Developments

✅ In October 2025, the U.S. Food and Drug Administration (FDA) approved an expanded use of Regeneron Pharmaceuticals' immunotherapy drug Libtayo as an adjuvant treatment for adult patients with cutaneous squamous cell carcinoma (CSCC), a high-risk skin cancer type, following surgery and radiation. This decision is supported by a late-stage clinical trial with 415 patients, in which Libtayo reduced the risk of cancer recurrence or death by 68% compared to a placebo.

✅ In September 2025, proton beam radiotherapy was found to result in similar oncologic outcomes with less toxicity and improved quality of life than intensity-modulated radiation therapy (IMRT) in patients with head and neck cancers, according to results of an MSK-led clinical trial presented at the 2025 American Society for Radiation Oncology Annual Meeting.

✅ In September 2025, a phase III clinical trial found that hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedules in limited-stage small cell lung cancer (LS-SCLC), according to findings presented at the World Conference on Lung Cancer 2025.

Japan: Recent Industry Developments

✅ In September 2025, a Japanese multicenter registry study evaluated the efficacy and safety of particle beam therapy for biliary tract cancer, highlighting its potential in reducing radiation-induced toxicities.

✅ In September 2025, a study presented at the 2025 American Society for Radiation Oncology Annual Meeting found that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes for patients with prostate cancer, suggesting that IMRT may be a viable alternative to proton therapy in certain cases.

✅ In September 2025, researchers from Korea, the U.S., and Germany presented findings at the American Society for Radiation Oncology (ASTRO) 2025 annual meeting, highlighting a promising breakthrough in arthritis treatment. Low-dose radiation therapy-once considered outdated-can significantly reduce joint pain and improve mobility in individuals suffering from osteoarthritis, especially in the knees, hands, and other affected joints.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/radiation-toxicity-treatment-market?sb

Radiation toxicity treatment involves therapies and interventions to manage the harmful effects of ionizing radiation on the body. Treatments include colony-stimulating factors, potassium iodide, Prussian blue, and other supportive measures to mitigate acute and chronic radiation syndromes, protect organs, and improve patient recovery.

Recent Mergers and acquisitions:

United States: Recent M&A Developments

✅ In October 2025, Shuttle Pharmaceuticals announced the acquisition of Molecule.ai for $10 million, marking its entry into AI-driven drug discovery. This strategic move aims to enhance the development of targeted therapies for radiation-induced toxicities.

✅ In April 2025, Sun Nuclear, a Mirion Medical company, acquired Oncospace, a provider of cloud-based, AI-powered solutions for radiation oncology. This acquisition underscores a commitment to integrating advanced technology to improve treatment outcomes.

✅ In June 2025, Elekta acquired assets from its distributor in Croatia, strengthening its market position and enhancing cancer treatment capabilities in the region. This move is part of Elekta's strategy to expand its global footprint in radiation oncology.

Japan: Recent M&A Developments

✅ In September 2025, Leo Cancer Care raised $40 million in venture funding led by Catalio Capital Management. The company is developing a cancer treatment system designed to simplify radiation therapy, aiming to enhance treatment accessibility and efficiency.

✅ In July 2025, Prisma Health invested $50 million to acquire the Ethos adaptive radiotherapy system from Varian, a Siemens Healthineers company. This acquisition aims to provide cancer patients with more precise and personalized care through AI-driven treatment and planning processes.

Key Players:

=> Amgen, Jubilant Pharma Limited, Tanner Pharma Group, Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG, Recipharm AB, Mission Pharmacal Company, Partner Therapeutics, Inc., Novartis AG, Mylan NV, and Coherus Biosciences Inc. among others.

Growth Forecast Projected:

The Global Radiation Toxicity Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Radiation Toxicity Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=radiation-toxicity-treatment-market

Key Segments:

➥ By Treatment: Colony Stimulating Factors, Potassium Iodide, Prussian Blue, Diethylenetriamine Pentaacetic Acid, Others

➥ By Indication: Acute Radiation Syndrome, Bone Marrow Syndrome, Gastrointestinal Syndrome, Cardiovascular Syndrome, Chronic Radiation Syndrome

➥ By Radiation Type: Ionizing Radiation, Alpha Radiation, Beta Radiation, Gamma Radiation, Non-ionizing Radiation

➥ By End-User: Hospitals, Specialty Clinics, Others

Regional Analysis for Radiation Toxicity Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Radiation Toxicity Treatment producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Radiation Toxicity Treatment revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/radiation-toxicity-treatment-market?sb

FAQ

What is the current size of the Radiation Toxicity Treatment Market?

A: In 2022, the Radiation Toxicity Treatment Market was valued at US$ 2.9 billion, reflecting its strong industry presence.

Q2: How large is the Radiation Toxicity Treatment Market expected to be by 2030?

A: By 2030, industry forecasts suggest the Radiation Toxicity Treatment Market will grow to around US$ 4.6 billion, demonstrating significant expansion.

Q3: What is the growth rate of the Radiation Toxicity Treatment Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 6.1% during the forecast period from 2023 to 2030.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.